207 related articles for article (PubMed ID: 30540120)
21. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.
Thomson IG; Gotley DC; Barbour AP; Martin I; Jayasuria N; Thomas J; Smithers BM
Gastric Cancer; 2014 Jan; 17(1):152-60. PubMed ID: 23474836
[TBL] [Abstract][Full Text] [Related]
22. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
23. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of extended D2 resection for proximal gastric cancer.
Volpe CM; Driscoll DL; Miloro SM; Douglass HO
J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
[TBL] [Abstract][Full Text] [Related]
26. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
Macalindong SS; Kim KH; Nam BH; Ryu KW; Kubo N; Kim JY; Eom BW; Yoon HM; Kook MC; Choi IJ; Kim YW
BMC Cancer; 2018 Jan; 18(1):73. PubMed ID: 29329569
[TBL] [Abstract][Full Text] [Related]
27. Short-term and long-term risk factors in gastric cancer.
Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China.
Wang Z; Ma L; Zhang XM; Zhou ZX
Asian Pac J Cancer Prev; 2014; 15(17):7219-22. PubMed ID: 25227817
[TBL] [Abstract][Full Text] [Related]
29. Current concepts in gastric cancer surgery.
Schumacher IK; Hunsicker A; Youssef PS; Lorenz D
Saudi Med J; 2002 Jan; 23(1):62-8. PubMed ID: 11938366
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center.
Costa WL; Coimbra FJ; Fogaroli RC; Ribeiro HS; Diniz AL; Begnami MD; Mello CA; Fanelli MF; Silva MJ; Fregnani JH; Montagnini AL
Radiat Oncol; 2012 Oct; 7():169. PubMed ID: 23068190
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
32. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
33. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.
Woo Y; Goldner B; Ituarte P; Lee B; Melstrom L; Son T; Noh SH; Fong Y; Hyung WJ
J Am Coll Surg; 2017 Apr; 224(4):546-555. PubMed ID: 28017807
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
Roukos D; Schmidt-Mathiesen A; Encke A
Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
[TBL] [Abstract][Full Text] [Related]
36. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas.
Talaiezadeh AH; Asgari M; Zargar MA
Asian Pac J Cancer Prev; 2015; 16(13):5253-6. PubMed ID: 26225661
[TBL] [Abstract][Full Text] [Related]
37. Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.
Dittmar Y; Rauchfuss F; Goetz M; Jandt K; Scheuerlein H; Heise M; Settmacher U
Langenbecks Arch Surg; 2012 Jun; 397(5):745-53. PubMed ID: 22307547
[TBL] [Abstract][Full Text] [Related]
38. [Long-term outcome of stomach carcinoma achieved in an Austrian standard hospital with an oncologic focus].
Jagoditsch M; Pertl A; Jatzko GR; Denk H; Stettner HM
Chirurg; 2001 Jul; 72(7):822-31. PubMed ID: 11490761
[TBL] [Abstract][Full Text] [Related]
39. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
[TBL] [Abstract][Full Text] [Related]
40. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.
Roviello F; Marrelli D; Morgagni P; de Manzoni G; Di Leo A; Vindigni C; Saragoni L; Tomezzoli A; Kurihara H;
Ann Surg Oncol; 2002 Nov; 9(9):894-900. PubMed ID: 12417512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
